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Abstract 21 
 The administration of diets with different protein/energy ratios induce variable but distinctive 22 
responses in rats; an excessive protein content tends to decrease fat accumulation, but reversion of 23 
this ratio tends to increase adipose tissue mass. The fate of N derived from amino acid metabolism 24 
is not only dependent on energy and dietary protein; the increased excretion of urea elicited by 25 
high-protein diets contrasts with the lower urea excretion (despite excess dietary protein and 26 
energy) in rats fed a cafeteria diet. After one month of exposure to high-protein (HPD) or cafeteria 27 
(CD) diets, we administered a gavage of 
15
N-arginine to undisturbed adult male rats, in order to 28 
trace the utilization of this not-recyclable-N amino acid under diets with different protein/energy 29 
relationships. Rats fed high-protein diet excreted higher amounts of N in urine and showed much 30 
lower gastrointestinal content of label. The CD rats decreased the excretion of urine N. Both groups’ 31 
N balance showed a significant proportion of N not-accounted-for (but excreted nevertheless), the 32 
proportion being especially large in the HPD group. In conclusion, the process of disposal of amino 33 
acid N through the so far unknown pathway for "non-accounted-for N" is, thus essentially 34 
dependent on excess amino acid availability; independently of urea cycle operation and diet energy 35 
content. 36 
 37 
Introduction 38 
 The considerable worldwide extension of metabolic syndrome, and the widely extended 39 
therapeutic failure in the treatment of one of its main and patent symptoms, obesity, 
1
 has spurned a 40 
renewed interest in the use of modified-composition diets for its treatment 
2
. Evidently, low- and 41 
very low-energy diets significantly affect the body weight of the patients, often for a time, but the 42 
changes are seldom permanent. 
3,4
 Further to that, morbid obesity has been found to be practically 43 
impervious to dietary treatments. 
5
 44 
 After the growing disenchantment with most hypocaloric diets for obesity treatment,
 6
 alone 45 
or combined with drugs and exercise, ketogenic, dissociate, and high-protein diets have been tested, 46 
and then widely used with limited success, if any.
7,8,9
 High-protein diets, are widely used by 47 
sportsmen and body builders, in the assumption that excess dietary protein increases body muscle 48 
mass and helps eliminate fat tissue.
10
 Most of the subjects consuming these diets also limit the 49 
intake of lipid and carbohydrate, and often combine the dietary manipulation with strenuous 50 
exercise training and the consumption of anabolic hormones and dietary supplements.
11
 The 51 
extreme dangers that these cocktails may produce have been repeatedly analysed, exposed and 52 
denounced.
12
 In any case, the aura of high-protein diets remain as a –possibly— last ditch for the 53 
dietary treatment of obesity.
13
 
 
54 
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 The problem is, however, that our knowledge of body amino acid metabolism, and the fate of 55 
dietary amino acids, and even the pathways used, has been neglected in the last decades.
14
 High-56 
protein diets have been used for the treatment of obesity without actually knowing how the dietary 57 
modification may alter the energy homoeostasis of the body and, especially, ignoring the elaborated 58 
mechanisms that prevent the loss of "precious" 2-amino N, especially that of essential amino 59 
acids.
15
 This well-known evolutionary trend maintains alive perhaps, the most disfavoured half of 60 
the World’s population, but we do not know yet (in their full extent) the mechanisms and regulative 61 
paths that determine this biological trait.
16
 62 
 The results obtained so far with high-protein diets are a widely discordant mixed bag, since 63 
there is no uniform pattern of results obtained from different experimental designs, and more often 64 
than not the effects observed fall well within the wide range of variation of "normal" diets.
17
 In 65 
many experiments done on rodents, the additional dietary N load often consists of purified, high 66 
quality protein. This fact makes even more complicated the evaluation of the results, since they 67 
combine the alteration of diet protein proportion with the higher essential amino acid availability, 68 
and modifications in energy density and the proportions of carbohydrate and lipids.
18,19
 The case of 69 
cafeteria diets is paradigmatic, they are hyperlipidic,
20
 but their protein content is usually in the 70 
higher range of normalcy.
21
 However, urea production, i.e. amino acid oxidation, is decreased, and 71 
the difference is not compensated by a parallel body protein accrual. 
22
 72 
 In animal studies, dietary supplementation with arginine improves muscle protein deposition 73 
and intramuscular lipid concentrations, while reducing fat mass.
23
 These studies suggest that 74 
arginine regulates lipid and protein content in a tissue-specific way.
24
 Thus, the lipogenic responses 75 
of adipocytes to arginine depend on the cell type and differentiation stage.
25
 From these data, it 76 
seems that any arginine surplus is oxidized.
26
 However, an “arginine paradox” has been observed: 77 
the more arginine enters the body, more is destroyed, affecting metabolic processes, such as the 78 
production of nitric oxide 
27
.  79 
 In spite of the technical complexities inherent to the use in vivo of stable isotopes, there are 80 
multiple advantages of using guanido group-labelled arginine as a tracer for dietary protein fate. 81 
Arginine is relatively abundant in proteins,
27
 and is a key intermediate of the urea cycle. Most of the 82 
waste N goes through the urea cycle and is consequently incorporated to the guanido group of 83 
arginine, which is practically not recycled,
28
 thus, it cannot intervene (and be diluted) in 84 
transamination processes, a main reason why it has been used often in N tracer studies, including 85 
analyses of protein turnover.
29
 These metabolic patterns make arginine an excellent candidate to 86 
follow amino acid utilization by different tissues after an oral load and determine the differences of 87 
amino acid metabolic use, and regulation, between cafeteria and high-protein diet.  88 
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 89 
 90 
Experimental Methods 91 
Animals and experimental setup 92 
 All animal handling procedures and the experimental setup were carried out in accordance 93 
with the animal handling guidelines of the European, Spanish and Catalan Authorities. The 94 
Committee on Animal Experimentation of the University of Barcelona authorized the specific 95 
procedures used (DAAM 6911). This limited keeping the animals isolated in metabolic cages to a 96 
maximum of 24 h to prevent unacceptable levels of stress. 97 
 Nine-week-old male Wistar rats (Janvier, Le Genest-Saint-Isle, France) were used. The 98 
animals were randomly divided into three groups (N = 6 each) and were fed ad libitum, for 30 days, 99 
either standard rat chow (SD) (Teklad 2014, Teklad diets, Madison WI, USA) (initial rat weight 100 
356±5 g), a simplified cafeteria diet (CD) 
21
 (initial rat weight 350±6 g), or high-protein diet (HPD) 101 
(initial rat weight 354±6 g). All animals had free access to water. They were housed in 2-rat solid-102 
bottom cages, and were kept in a controlled environment (lights on from 08:00 to 20:00, 103 
temperature 21.5-22.5ºC and 50-60% humidity). Body weight and food consumption were recorded 104 
daily. Calculation of food ingested was done as previously described by weighing the differences in 105 
food offered and debris left.
30
 106 
Diets 107 
 In the standard diet (Teklad 2014) (Table 1), 20% of digestible energy was derived from 108 
protein, 13% from lipids, and 67% from carbohydrates (including 10% from low MW 109 
oligosaccharides). The main components of standard diet were (as specified by manufacturer): 110 
wheat middlings, ground wheat, ground corn, corn gluten meal, calcium carbonate, soybean oil and 111 
mineral and vitamin supplements.  112 
 The cafeteria diet (CD) was formed by plain cookies spread with liver pâté, bacon, standard 113 
chow pellets, water and milk supplemented with 300 g/L sucrose plus 10 g/L of a mineral and 114 
vitamin supplement (Meritene, Nestlé, Esplugues, Spain). All components were kept fresh (i.e. 115 
renewed daily). From the analysis of diet components and the ingested items, we calculated that, in 116 
CD, a mean 41% of energy was derived from lipids, 12% of energy was derived from protein, and 117 
47% of energy was derived from carbohydrates (20% from oligosaccharides). The analysis of food 118 
consumption of rats on the cafeteria diet showed that the ingestion of the different food choices was 119 
fairly constant in type and quantity consumed per rat and day as previously observed 
21,22
. The 120 
computed nutrient consumption along the period studied, expressed as a percentage of total energy 121 
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ingested was 20.3% for pellet, 26.1 % for cookies, 17.9% for bacon, 16.52% for pâté and 19.2% for 122 
sugar-enriched milk. 123 
 The high-protein diet (HPD) was prepared by the addition of high quality protein (cow milk 124 
casein) (J.Escuder, Rubí, Spain) and low quality protein (fish gelatin) (J.Escuder), to ground 125 
standard chow. The mix (16.5 g of standard chow + 2.35 g of casein + 2.05 g of gelatin + 0.2 mL of 126 
sunflower oil + 17 mL of water) was thoroughly mixed to a paste and then extruded from syringes 127 
to form pellets, dried at 40ºC for 24 hours. Aversion tests to this diet gave negative results. The 128 
energy derived from proteins for the HPD was 41%, that from lipids was 12% and that derived from 129 
carbohydrates was 47%. Nitrogen content of all diet components was measured with a semi-130 
automatic Kjeldahl procedure using a ProNitro S system (JP Selecta, Abrera, Spain). Lipid content 131 
was measured with the Folch et al. method.
31 
132 
 Supplemental Table 2 shows the mean fatty acid composition of the diets. These data were 133 
calculated for each food item according to a previous study 
32
 using a standard method for fatty acid 134 
analysis
 33
. The cafeteria diet showed higher levels of most fatty acids than controls, as expected, 135 
except for linoleic acid, which was present in higher quantities in standard diet.  136 
 137 
Arginine-
15
N tracer gavage and tissue sampling  138 
 After 29-days of dietary treatment, the rats were given a gavage of 1 mL of 5% bovine serum 139 
albumin (Sigma-Aldrich, St Louis, MO USA) in water, containing 60 pmol of L-arginine-140 
[guanidineimino-
15
N]-hydrochloride (98% atom 
15
N) (Sigma Aldrich, Munich, Germany), using a 141 
polyethylene intra-gastric cannula.  142 
 After the gavage, the rats were transferred for 24 h to individual plastic metabolic cages 143 
(Techniplast Gazzada, Buggugiate, Italy), maintaining the environmental and dietary conditions 144 
described, but recovering urine and faeces separately. 145 
 On day 30, the rats were anesthetized with isoflurane and then killed by exsanguination with a 146 
dry-heparinized syringe, through the exposed aorta. Tissue samples (liver, kidneys, three white 147 
adipose tissue (WAT) locations, interscapular brown adipose tissue (IBAT), hind leg muscle and 148 
intestines) were dissected, cleaned (gut) and rapidly frozen in liquid nitrogen. They were 149 
maintained at -70ºC until processed for analyses. Plasma and erythrocyte fractions were obtained by 150 
centrifugation of the blood. The remaining carcass, blood and dissection debris were sealed in 151 
polyethylene bags, which were subsequently autoclaved at 120°C for 2 h,
22
 the bag contents were 152 
weighed and then minced to a smooth paste with a blender (obtaining a total rat homogenate).  153 
 An additional control group of six control diet-fed animals was used to obtain the basal values 154 
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of N content. These rats (360±8 g) were reared in parallel to the other experimental groups, but they 155 
were not given the 
15
N-Arg gavage. No differences in weight, and food consumption were observed 156 
when comparing this group and the SD.  157 
 158 
Metabolite analyses 159 
 Urine and plasma parameters were measured using commercial kits (BioSystems, Barcelona, 160 
Spain): urea (#11537), glucose (#11504), total cholesterol (#11505) and triacylglycerols (#11528). 161 
Total proteins were measured in tissue homogenates, total blood and plasma using the Lowry et al. 162 
method.
34
 Plasma samples were deproteinized with acetone 
35
 and the supernatants were used for 163 
amino acid analysis as previously described.
21
  164 
 165 
15
N Analysis 166 
 Aliquots of frozen tissues (about 200 mg) were homogenized in 2 mL of pure water 167 
(resistivity 18 MΩ) using a cell disruptor (IKA, Staufen, Germany), and then sonicated (Sonics 168 
Vibracell VC130PB, Sonics & Materials, Newtown, CT USA) to ensure complete cell disruption. 169 
The homogenates were then used directly for analysis. Aliquots of 5-10 µL of homogenized samples 170 
(equivalent to 0.5-1 mg of  fresh tissue) were introduced in tin capsules (3.3 x 5 mm; Cromlab, 171 
Barcelona, Spain), filled with Al2O3 as adsorbent. The microcapsules were sealed, and used for 
15
N-172 
enrichment measurement. The analyses were done with a Delta C gas chromatography-combustion-173 
isotopic ratio mass spectrometer (GC-C-IRMS) (Finnigan MAT, Bremen, Germany) coupled to an 174 
elemental analyser (Flash 1112; Thermo Fisher, Waltham MA USA). 175 
 The 
15
N/
14
N isotope ratios were expressed on a relative scale as deviation, referred as ∂ units 176 
with the notation ‰ (parts of thousand), relative to the isotope ratio content of international 177 
standards.
36
 178 
The corresponding ∂ values for the samples were determined from the equation:  179 
    ∂ = ([Raa/Rat]-1) x 1000 180 
Where Raa  is the 
15
N/
14
N  ratio obtained for each sample and Rat correspond to the 
15
N/
14
N ratio of 181 
the standards. 182 
The values of ∂ were expressed as atom percentage (at%) using the formula: 183 
    Nat% = 100 x (
15
N/[
15
N +
14
N]) 184 
The net enrichment (atom percentage excess) in 
15
N was calculated from the difference between the 185 
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atom percentages of samples and their corresponding blanks (i.e. the results obtained from the same 186 
tissues of control rats, which did not receive the labelled arginine gavage): 187 
   Atom percentage excess = at% sample – at% blank. 188 
 Finally, using the values of atom percentage excess, arginine molecular weight and 189 
Avogadro’s number, we computed the results to express the proportion of isotopic marker in 190 
relation to the total amount of arginine ingested (i.e. the sum of diet and gavage). 191 
Statistical analysis 192 
 Statistical comparisons were carried out using one- or two-way ANOVA analyses with the 193 
Prism 5 program (GraphPad Prism, Palo Alto CA, USA). 194 
 195 
Results 196 
 Table 2 shows the rat size and energy intake during the 30-day dietary treatment. The 197 
cafeteria-fed group showed the highest weight increase during treatment, and also the highest 198 
energy intake and growth rate, whereas the HPD group showed the lowest values for all these 199 
parameters. The energy cost of growth was higher in CD and HPD groups than in SD. The mean 200 
nitrogen intake was higher in HPD group than either SD and CD groups. 201 
 Cafeteria-fed rats experienced marked increases in the weights of three different white 202 
adipose tissue depots (alone or combined weight) in contrast with the lowest values of the HPD 203 
group. The HPD  rats showed, also, lower small intestine weights. These data are shown in detail in 204 
Supplemental Table 1. 205 
 Plasma values for metabolites are presented in Table 3. The HPD group had the highest 206 
plasma urea concentrations. Arginine levels were higher in the CD and in the HPD groups 207 
compared with SD whereas ornithine was lower in the CD group. By contrast, the HPD rats showed 208 
the lowest citrulline levels. The diet treatment did not influence significantly the plasma levels of 209 
glucose, cholesterol and total protein main excretion fractions. 210 
 Figure 1 shows the proportions of ingested 
15
N label for all three dietary groups, expressed as 211 
accrued and excreted fractions. There were no significant differences between the groups in the 212 
proportion of 
15
N accrual. However, when the values of non-accrued (i.e. excreted) 
15
N atoms were 213 
sorted in their main excretion fractions, the HPD group showed an almost nil presence of 
15
N in 214 
stool and gastrointestinal content, this way partly compensated by the highest values of urine-215 
excreted label, and a large proportion of label lost (not-accounted for). Compared with the control 216 
SD rats, the CD group only showed a lower urine-excreted label and, a higher proportion of the not-217 
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accounted-for N fraction.  218 
 Analyses of urine urea levels showed that in all groups, urine N was justified in proportions 219 
higher than 98% by urea, making the values for urea N and urine N practically interchangeable. 220 
 Table 4 depicts the distribution of total 
15
N atoms in tissues. When expressed as percentage of 221 
absorbed N, the values were highest for kidney in the HPD group and for epidydimal and 222 
retroperitoneal WAT in CD rats. However, when the data were expressed per g of protein, the 223 
cafeteria-fed rats showed higher values in epidydimal WAT and plasma, but lower in the IBAT than 224 
in SD group. The low levels of 
15
N in the IBAT of the cafeteria group were also observed in the 225 
HPD group. 226 
 Figure 2 shows the relationship between 
15
N atoms and total diet arginine ingestion and with 227 
respect to whole-body arginine. The HPD group showed the lowest values for the number of 
15
N 228 
atoms retained in relation to the arginine ingested. Both, the HPD and CD animals showed lower 229 
values for total 
15
N content than the SD controls. Finally, the HPD rats showed the lowest arginine 230 
(in fact, guanido group) specific activity (i.e., the 
15
N / total-Arg ratio).  Nevertheless, despite the 231 
differences exposed, no statisticalsignificant differences in arginine accrual were found between the 232 
three dietary treatments used. 233 
 234 
Discussion 235 
  236 
 The golden rule of survival for mammals establishes that glycaemia has to be maintained, and 237 
amino acids, especially the essential ones, preserved.
37
 In our experimental model, the animals had 238 
no problems of amino acid availability; the only plausible question was the need to dispose of their 239 
excess. There was, neither, any deficit in dietary energy availability; at least theoretically, since the 240 
energy density of the food of HPD diet was the same than that of SD (that of CD was higher), their 241 
differences rested only in the proportion of nutrients offered. However, this factor dramatically 242 
modified the handling of ingested protein. In the SD group, the accrual of labelled arginine was 243 
higher than in the other groups, which resulted in the highest labelled arginine specific activity(and, 244 
in contrast that of HPD group, lowest). The label in the intestinal content and stool contained a large 245 
proportion of that ingested in both SD and CD groups, but  was almost absent in HPD animals, 246 
which is in agreement with a speedier and more efficient digestion of protein in diets with high 247 
protein content.
38
 This seems to be clearly an adaptive modulation of the gut function, which ability 248 
to process foods is modified according to the composition of the diet within a relatively short 249 
period.
39 
250 
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 Most of the absorbed label was found in the total homogenate, largely because skeletal muscle 251 
the main quantitative receptor because of its size (about 45 % of the body lean mass) and high 252 
protein content,
40
 liver concentrated a significant amount of the label, probably because of its 253 
critical role in amino acid homoeostasis and disposal, 
41
 a task shared (for dietary protein) with the 254 
intestine.  255 
 The changes observed in urea excretion can be traced, too, to the primary energy partitioning 256 
role of intestine. High availability of carbohydrate in enterocytes raises the activity of the pentose-P 257 
pathway, raising the levels of NADPH, which modulates the disposal of amino N by activation of 258 
the synthesis of ornithine and citrulline,
42
 precursors of (and fuel to sustain) the liver urea cycle.
43
 259 
This situation explains the case of SD and HPD groups, but not that of CD, since there was 260 
sufficient dietary carbohydrate in the gut but the urea cycle was not activated as expected. In fact, 261 
all the substrate relationships described respond to corollaries of the golden rules of homoeostasis 262 
for survival, in short: high lipid saves glucose. This is so because lipids were present only in limited 263 
amount and/or sporadically in the diet of our long line of ancestors (and in the diet of present-day 264 
rodents).
44
 When lipid is present in the bloodstream, the metabolic meaning is clear: there are no 265 
dietary sources of energy and we are consuming reserves (our own lipid); then we must save energy, 266 
and save glucose, preserve amino acids, etc.
45
 High carbohydrate availability translates into a large 267 
amount of dietary energy that allows us to save amino acids, the extent of salvage being related to 268 
their own relative availability.
46
High dietary protein spurns amino acid oxidation for use as energy, 269 
since there is no place where excess N can be stored, and protein is a fair source of energy too.
47
 270 
Nevertheless, low dietary protein is a red line that requires its preservation for survival.
48
 HPD rats 271 
oxidize dietary protein as energy source to a high level (resulting in high urea excretion), because 272 
the relative amount of carbohydrate was lower than under standard conditions. However, not all 273 
excess amino acids go through the canonical urea cycle pathway, since a large proportion of N is 274 
eliminated through alternative unknown pathways (N gap), as previously reported 
49 
and repeated 275 
here. 276 
 The results obtained for CD rats agree with a number of previously published papers, i.e. 277 
cafeteria diet increases body size, the mass of adipose tissue and the accrual of protein, increases 278 
appetite and generates a N-gap, higher than that of SD, in their nitrogen balance.
21,22
  279 
 CD rats showed a marked decrease in urea excretion, despite having a protein intake similar 280 
to that of the SD group. Clearly, the high presence of dietary lipid (and excess energy availability) 281 
blocked the oxidation of amino acids, and inhibited the urea cycle, as previously described.
48
. 282 
 The HPD diet elicits a clear correlation between higher dietary 2-amino N intake and 283 
increased urea excretion.
51
 The rats fed the HPD were slightly smaller, with less adipose tissue than 284 
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the SD-fed rats, and their energy intake was lower. This may be, at least in part, a consequence of 285 
the higher satiating effect of protein;
52
 but protein intake induces, also, a higher thermic response to 286 
food than other nutrients,
53 
thus decreaseing the efficiency of growth, as observed here. In any case 287 
the most important differences between dietary groups may lie, in the cost of live tissue deposition 288 
since, contrarily to what we expected, the labelled arginine that found its way into body protein was 289 
maximal in SD group and minimal in HPD group. This counterintuitive result implies that the use 290 
of amino acids for energy takes its toll, lowering considerably the overall energy efficiency of the 291 
animal. 292 
 In all groups, the proportion of N excreted with respect to that ingested, and the distribution of 293 
label between organs and tissues was similar, but the extent of the "unaccounted for N" (in any case, 294 
excreted) was higher in both CD and HPD trats than in rats fed the SD. Thus, the explanation of 295 
urea cycle inhibition as justification for the activation of other (so far unknown) pathways than the 296 
urea cycle for N disposal, used to explain the existence of the wide N balance gap in CD-fed rats 297 
could not be sustained.
49
 The HPD rats had an apparently fully functional urea cycle, as proven by 298 
their high plasma urea, and high daily urinary N excretion, again as urea, but they showed an N-gap 299 
that doubled that of CD rats. This unexplained form of N excretion has been proven in a number of 300 
different settings,
54
 and has been found to be directly related to the diet.
22
 It has been attributed both 301 
to high energy and/or lipid intake, but the results presented here seem to point further away, to the 302 
existence of a regular mechanism for the disposal of excess available amino N from amino acids. 303 
This is a difficult task because evolution has fine-tuned our highly effective mechanisms to preserve 304 
amino N, leaving almost no space for disposal of eventual (rare in Nature) excesses. 305 
 In the case of cafeteria diet, previous studies have shown that the excess of lipids hampers the 306 
utilization of glucose because of insulin resistance.
55
 The unused glucose tends to accumulate and 307 
create a problem by itself, which usually ends in the form of additional lipid stores and often results 308 
in type 2 diabetes.
56
 The flow of dietary protein-derived amino acids cannot be processed at the 309 
required speed through the urea cycle because the excess of glucose and energy just prevents it. 310 
However, the increasing excess of amino N could not be stored, and, consequently is eliminated in 311 
significant proportions through the postulated N-gap-related pathway.
22,49
 This partial parallelism in 312 
N disposal between CD and HPD groups suggests that the N-gap pathway must be a well-313 
established mechanism, regulated in some way by its substrates’ excess. The data presented here 314 
clearly show this high capacity and gross modulation. The activation of this postulated (albeit 315 
unknown) process is not dependent on the excess of available energy. It is related, instead to the 316 
excess of amino acids available built-up by the combination of high dietary supply and because the 317 
regular oxidative pathways are blocked by eons-old preservation schemes.
57
 The HPD rats have a 318 
Page 10 of 22RSC Advances
R
S
C
A
dv
an
ce
s
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
14
 Ju
ly
 2
01
6.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
t d
e B
ar
ce
lo
na
 o
n 
15
/0
7/
20
16
 0
6:
48
:2
3.
 
View Article Online
DOI: 10.1039/C6RA11039H
11 
 
fully active urea cycle, uninhibited by high glucose or lipid, which would make the alternate 319 
pathway unnecessary unless it were "regulated" by other parameters such as an excess of amino 320 
acid N. This elusive pathway seems conceived more as an emergency safety mechanism rather than 321 
as a developed efficient energy-providing pathway. The high cost of deposition of energy observed 322 
in the HPD and CD rats may suggest that the mechanism is not energetically efficient.
58
 323 
 In sum, in the present study, developed using arginine marked with the stable isotope 
15
N, we 324 
have observed that the intestine and liver exert the initial triage of dietary nutrients, that in the case 325 
of amino acids is controlled by the availability of 2-amino N in relation to carbohydrate, but also by 326 
the amount (and eventual excess) of amino acids. The main regular mechanism of N disposal is the 327 
urea cycle, but a repeatedly detected and yet unknown N gap-generating pathway seems to take care 328 
of the surplus of amino acid N that apparently could not be processed via urea cycle. The 329 
parallelism with cafeteria diet, which urea synthesis pathway is inhibited by excess lipid (and 330 
carbohydrate) energy proves that this unknown mechanism is widely extended and not only 331 
dependent on excess energy but on an excess of amino acids. 332 
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TABLE 1 Composition of the diets used 424 
  425 
parameter diets 
SD CD HPD 
 
Carbohydrates  
 
480 
 
545 
 
334 
Fibre  22 13 19 
Ashes  47 15 33 
Lipid  40 211 38 
Protein  143 138 286 
Metabolizable 
energy * 
12 16 12 
 
Amino 
acid 
content 
Asx 9.1 9.6 17 
Glx 29 23 48 
Ala 9.0 4.9 17 
Gly 7.1 6.8 28 
Thr 5.1 5.3 9.2 
Pro 12 10 40 
Ser 7.2 5.6 13 
Leu 14 9.6 21 
Ile 6.1 5.7 11 
Val 6.9 6.2 13 
Phe 7.0 5.4 12 
Tyr 4.2 2.9 8.3 
Met 3.1 2.1 5.5 
Cys 3.0 1.6 2.5 
Lys 7.1 7.2 15 
His 4.1 3.3 6.3 
Arg 8.1 6.7 15 
Trp 2.0 1.3 2.7 
 426 
The data are presented in g·kg
-1
, except for metabolizable energy (*) expressed in MJ.kg
-1
. The data 427 
corresponding to CD were calculated from the composition of the mean diet (i.e. mix of foods) 428 
intake. 429 
 430 
 431 
 432 
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 433 
Table 2 Weight, and intake (energy, nitrogen) of male rats subjected to diets with different 434 
protein content 435 
parameter units diets P 
SD CD HPD 
Weight (final)  g 491 ± 11
AB
 532 ± 16
A
 461 ± 17
B
 0.0175 
Weight increase  g 127 ± 8
A
 147 ± 11
A
 84 ± 9
B
 0.0021 
Energy intake  kJ d
-1
 370 ± 4
A
 556 ± 13
B
 336 ± 10
A
 <0.0001 
Nitrogen intake  mg d
-1
 696 ± 7
A
 720 ± 18
A
 1531 ± 41
B
 <0.0001 
Cost of accrual  kJ g
-1
 88.1 ± 5.0
A
 116 ± 8
B
 118 ± 5
B
 0.0112 
 436 
The data are the mean ± SE of six different animals. Statistical comparisons between groups: One-437 
way ANOVA; post-hoc test (Tuckey test): groups with different superscript letters are statistically 438 
different (P<0.05). 439 
440 
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 441 
Table 3 Plama metabolite levels of rats subjected to diferent diets. 442 
 443 
parameter units diets P 
SD CD HPD 
Glucose  mM 10.3 ± 0.7
A 
10.1 ± 0.6
A
 10.2 ± 1.6
A
 NS 
Triacylcglycerols mM 0.99 ± 0.08
A 
1.32 ± 0.15
A
 0.90 ± 0.06
B
 0.0292 
Cholesterol  mM 2.35 ± 0.62
A 
1.05 ± 0.29
A
 0.91 ± 0.23
A
 NS 
Urea  mM 5.38 ± 0.34
A 
5.41 ± 0.39
A
 6.73 ± 0.15
B 
0.0112 
Total proteins  g L
-1
 57.1 ± 2.7
A 
55.4 ± 1.3
A
 52.9 ± 1.5
A
 NS 
Arginine  µM 107 ± 15
A 
164 ± 8.3
B
 146 ± 10
AB
 0.0032 
Ornithine  µM 228 ± 17
A 
66.1 ± 8.1
B
 241 ± 22
A
 <0.0001 
Citrulline  µM 40.2 ± 2.2
A 
51.3 ± 4.2
A
 24.1 ± 3.2
B
 0.0001 
 444 
The data are the mean ± SE of six different animals. Statistical comparisons between groups: One-way 445 
ANOVA; post-hoc test (Tuckey test): groups with different superscript letters are statistically different 446 
(P<0.05); NS = not statistically significant. 447 
 448 
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Table 4.  Total 
15
N atoms in tissues (expressed as a percentage of absorbed nitrogen) and total 
15
N atoms in tissues x 10
19
 (per gram of protein) in rats  
  subjected to different diets 
 
 
 
15
N accrued as % of absorbed N 
15
N x10
19 
atoms g
-1 
of tissue protein 
Parameter SD CD HPD P SD CD HPD P 
Liver 6.95 ± 1.17
A 
5.06 ± 1.50
A 
7.11 ± 1.15
A 
NS 3.25 ± 0.52
A 
2.15 ± 0.46
A 
2.44 ± 0.21
A 
NS 
Kidney 1.90 ± 0.37
AB 
1.28 ± 0.32
A 
2.83 ± 0.50
B 
0.0484 9.16 ± 2.45
A 
4.82 ± 1.06
A 
5.89 ± 0.51
A 
NS 
Epididymal 
WAT 
0.31 ± 0.04
A 
1.99 ± 0.62
B 
0.68 ± 0.24
AB 
0.0185 
2.77 ± 0.49
A 
11.4 ± 2.47
B 
3.70 ± 0.37
A 
0.0015 
Retroperitoneal 
WAT 
0.24 ± 0.02
A 
0.89 ± 0.29
B 
0.38 ± 0.07
AB 
NS 
2.82 ± 0.62
A 
1.82 ± 0.14
A 
3.00 ± 0.23
A 
NS 
Mesenteric 
WAT 
0.39 ± 0.06
A 
0.63 ± 0.31
A 
0.73 ± 0.23
A 
NS 
3.56 ± 0.76
A 
2.81 ± 0.74
A 
3.97 ± 0.76
A 
NS 
IBAT 0.10 ± 0.04
A 
0.09 ± 0.02
A 
0.27 ± 0.10
A 
NS 7.22 ± 1.11
A 
3.35 ± 0.87
B 
3.09 ± 0.47
B 
0.0062 
Small intestine 12.3 ± 2.0
A 
12.3 ± 2.1
A 
15.1 ± 3.1
A 
NS 25.7 ± 5.7
A
 14.6 ± 3.9
A 
20.1 ± 3.2
A 
NS 
Blood plasma 2.02 ± 0.52
A 
3.35 ± 0.75
A 
3.46 ± 1.24
 A 
NS 3.93 ± 0.46
A 
8.37 ± 1.54
B 
3.91 ± 0.57
A 
0.0079 
Blood cells 1.82 ± 0.32
A 
3.32 ± 1.04
A 
3.46 ± 1.04
A 
NS 0.87 ± 0.24
A 
0.86 ± 0.20
A 
0.76 ± 0.21
A 
NS 
Skeletal muscle 
* 
28.5 ± 1.4
A 
33.8 ± 9.1
A 
23.9 ± 2.8
A 
NS 
2.16 ± 0.74
A 
1.85 ± 0.59
A 
1.06 ± 0.18
A 
NS 
Rest of tissues 
(homogenate) 
44.1 ± 1.9
A 
37.8 ± 3.6
A
 43.3 ± 2.0
A 
NS 
1.85 ± 0.48
A 
1.55 ± 0.26
A 
1.29 ± 0.12
A 
NS 
 
 
*Striated muscle mass was estimated using previous reports (27). The data are the mean ± SE of six different animals. Statistical comparisons between groups: 
One-way ANOVA; post-hoc test (Tuckey test): groups with different superscript letters are statistically different (P<0.05); NS = not statistically significant. 
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LEGEND TO FIGURES 
Figure 1. Distribution of 
15
N atoms in different fractions of rats fed standard, cafeteria and high-
protein diets.  
A.Total atoms (expressed as a percentage of ingested label) were distributed in two large pools: 
accrued (white columns) and excreted (stacked black columns).  
The data are the mean ± SE of six different animals. Statistical comparisons between groups: Two-
way ANOVA: Accrued (P=0.0756), Excreted (P=0.5359). 
B. Total atoms excreted (expressed as a percentage of ingested label): gastrointestinal content plus 
faeces (brown columns) and urine and other ways of excretion (stacked yellow columns). 
The data are the mean ± SE of six different animals. Statistical comparisons between groups: Two-
way ANOVA: Gastrointestinal content plus faeces (P=0.0053), urine and other ways of excretion 
(P=0.0031). Pots-hoc Tuckey test: * = P < 0.05 vs SD group; • = P<0.05 of HPD vs CD group.  
C. Total 
15
N atoms excreted in other ways: urine (yellow columns) and non-accounted for N 
fractions (stacked pink columns).  
The data are the mean ± SE of six different animals. Statistical comparisons between groups: One-
way ANOVA for the different fractions different fractions: Urine (P=0.0053), Non-accounted for N         
(P=0.0189). Pots-hoc Tuckey test: * = P < 0.05 vs SD group; • = P<0.05 of HPD vs CD group.  
 
Figure 2. Number of 
15
N atoms ingested, specific activity of 
15
N atoms in relation to arginine 
ingestion and arginine accrued in 24 hours.  
Total body arginine content was estimated using previously published data (61).  
The data are the mean ± SE of six different animals. White columns: SD group, black columns: CD 
group, striped columns: HPD group. 
The data are the mean ± SE of six different animals. Statistical comparisons between groups: One-
way ANOVA; post-hoc test (Tuckey test): * = P < 0.05 vs SD group; + = P<0.05 of HPD vs CD 
group.  
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